179 related articles for article (PubMed ID: 22318909)
1. Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Liu HQ; An JZ; Liu J; Yang YF; Zhang HX; Zhao BY; Li JB; Yang HS; Chen ZN; Xing JL
Carcinogenesis; 2012 May; 33(5):1040-5. PubMed ID: 22318909
[TBL] [Abstract][Full Text] [Related]
2. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
3. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
4. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis.
Liu J; Yang Y; Zhang H; Zhao S; Liu H; Ge N; Yang H; Xing JL; Chen Z
Cancer; 2011 Sep; 117(18):4247-56. PubMed ID: 21387275
[TBL] [Abstract][Full Text] [Related]
5. Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients.
Qu F; Li R; He X; Li Q; Xie S; Gong L; Ji G; Lu J; Bao G
Mol Oncol; 2015 Mar; 9(3):727-39. PubMed ID: 25515040
[TBL] [Abstract][Full Text] [Related]
6. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.
Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G
Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253
[TBL] [Abstract][Full Text] [Related]
7. Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.
Chen Y; Qu F; He X; Bao G; Liu X; Wan S; Xing J
Ann Oncol; 2014 Apr; 25(4):869-876. PubMed ID: 24608194
[TBL] [Abstract][Full Text] [Related]
8. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.
Fu X; Wan S; Hann HW; Myers RE; Hann RS; Au J; Chen B; Xing J; Yang H
Eur J Cancer; 2012 May; 48(7):1014-22. PubMed ID: 22444598
[TBL] [Abstract][Full Text] [Related]
9. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Rohan T; Uher M; Matkulčík P; Zavadil J; Ostřížková L; Kiss I; Andrašina T; Válek V
Klin Onkol; 2020; 33(3):214-219. PubMed ID: 32683878
[TBL] [Abstract][Full Text] [Related]
11. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.
Chen J; Lai L; Lin Q; Huang W; Cai M; Zhu K; Huang M
Oncotarget; 2017 Jan; 8(1):408-417. PubMed ID: 27880724
[TBL] [Abstract][Full Text] [Related]
12. ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization.
Bannangkoon K; Hongsakul K; Sripongpun P; Kaewdech A; Chamroonkul N; Tubtawee T; Piratvisuth T
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3685-3692. PubMed ID: 34837928
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
14. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
[TBL] [Abstract][Full Text] [Related]
15. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
17. Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles.
Ren Z; Yue Y; Zhang Y; Dong J; Liu Y; Yang X; Lin X; Zhao X; Wei Z; Zheng Y; Wang T
Front Immunol; 2021; 12():624789. PubMed ID: 33717135
[TBL] [Abstract][Full Text] [Related]
18. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation.
Mishra G; Dev A; Paul E; Cheung W; Koukounaras J; Jhamb A; Marginson B; Lim BG; Simkin P; Borsaru A; Burnes J; Goodwin M; Ramachandra V; Spanger M; Lubel J; Gow P; Sood S; Thompson A; Ryan M; Nicoll A; Bell S; Majeed A; Kemp W; Roberts SK;
BMC Cancer; 2020 May; 20(1):483. PubMed ID: 32471447
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
